These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 34855461

  • 1. CD123 Expression Is Associated With High-Risk Disease Characteristics in Childhood Acute Myeloid Leukemia: A Report From the Children's Oncology Group.
    Lamble AJ, Eidenschink Brodersen L, Alonzo TA, Wang J, Pardo L, Sung L, Cooper TM, Kolb EA, Aplenc R, Tasian SK, Loken MR, Meshinchi S.
    J Clin Oncol; 2022 Jan 20; 40(3):252-261. PubMed ID: 34855461
    [Abstract] [Full Text] [Related]

  • 2. Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric KMT2A-Rearranged AML: Results From the Phase III Children's Oncology Group Trial AAML0531.
    Pollard JA, Guest E, Alonzo TA, Gerbing RB, Loken MR, Brodersen LE, Kolb EA, Aplenc R, Meshinchi S, Raimondi SC, Hirsch B, Gamis AS.
    J Clin Oncol; 2021 Oct 01; 39(28):3149-3160. PubMed ID: 34048275
    [Abstract] [Full Text] [Related]

  • 3. CD123 expression levels in 846 acute leukemia patients based on standardized immunophenotyping.
    Bras AE, de Haas V, van Stigt A, Jongen-Lavrencic M, Beverloo HB, Te Marvelde JG, Zwaan CM, van Dongen JJM, Leusen JHW, van der Velden VHJ.
    Cytometry B Clin Cytom; 2019 Mar 01; 96(2):134-142. PubMed ID: 30450744
    [Abstract] [Full Text] [Related]

  • 4. Immunoprofiling of leukemic stem cells CD34+/CD38-/CD123+ delineate FLT3/ITD-positive clones.
    Al-Mawali A, Gillis D, Lewis I.
    J Hematol Oncol; 2016 Jul 27; 9(1):61. PubMed ID: 27465508
    [Abstract] [Full Text] [Related]

  • 5. CD123 immunohistochemical expression in acute myeloid leukemia is associated with underlying FLT3-ITD and NPM1 mutations.
    Rollins-Raval M, Pillai R, Warita K, Mitsuhashi-Warita T, Mehta R, Boyiadzis M, Djokic M, Kant JA, Roth CG.
    Appl Immunohistochem Mol Morphol; 2013 May 27; 21(3):212-7. PubMed ID: 22914610
    [Abstract] [Full Text] [Related]

  • 6. A Leukemia-Associated CD34/CD123/CD25/CD99+ Immunophenotype Identifies FLT3-Mutated Clones in Acute Myeloid Leukemia.
    Angelini DF, Ottone T, Guerrera G, Lavorgna S, Cittadini M, Buccisano F, De Bardi M, Gargano F, Maurillo L, Divona M, Noguera NI, Consalvo MI, Borsellino G, Bernardi G, Amadori S, Venditti A, Battistini L, Lo-Coco F.
    Clin Cancer Res; 2015 Sep 01; 21(17):3977-85. PubMed ID: 25957287
    [Abstract] [Full Text] [Related]

  • 7. Clinical value of CD25/CD123 co-expression in acute myeloid leukemia patients.
    Aref S, Azmy E, El Ghannam D, Haroun M, Ibrahim L, Sabry M.
    Cancer Biomark; 2020 Sep 01; 29(1):9-16. PubMed ID: 32417762
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The effect of the detection of minimal residual disease for the prognosis and the choice of post-remission therapy of intermediate-risk acute myeloid leukemia without FLT3-ITD, NPM1 and biallelic CEBPA mutations.
    Zheng WS, Hu YL, Guan LX, Peng B, Wang SY.
    Hematology; 2021 Dec 01; 26(1):179-185. PubMed ID: 33594943
    [Abstract] [Full Text] [Related]

  • 11. A Real-world Perspective of CD123 Expression in Acute Leukemia as Promising Biomarker to Predict Treatment Outcome in B-ALL and AML.
    Das N, Gupta R, Gupta SK, Bakhshi S, Malhotra A, Rai S, Singh S, Prajapati VK, Sahoo RK, Gogia A, Sharma A, Kumar L.
    Clin Lymphoma Myeloma Leuk; 2020 Oct 01; 20(10):e673-e684. PubMed ID: 32561191
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group.
    Loken MR, Alonzo TA, Pardo L, Gerbing RB, Raimondi SC, Hirsch BA, Ho PA, Franklin J, Cooper TM, Gamis AS, Meshinchi S.
    Blood; 2012 Aug 23; 120(8):1581-8. PubMed ID: 22649108
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. FLT3-ITD DNA and mRNA levels in AML do not correlate with CD7, CD33 and CD123 expression.
    Soare DS, Radu E, Dumitru I, Popov VM, Bumbea H, Vlădăreanu AM.
    J Cell Mol Med; 2020 Jul 23; 24(13):7675-7679. PubMed ID: 32460405
    [Abstract] [Full Text] [Related]

  • 16. [The study of expression and prognostic value of CD123 in acute myeloid leukemia bone marrow blasts].
    Yue WQ, Tang GS, Liu M, Cheng H, Ding J, Wang T, Wang JM, Hu XX, Zhang WP, Chen L, Yang JM.
    Zhonghua Xue Ye Xue Za Zhi; 2017 Oct 14; 38(10):876-882. PubMed ID: 29166741
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.